These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26278156)

  • 1. A 39-gene signature is associated with early occurrence of distant metastasis in primary lymph-node negative breast cancers.
    Xia R; Chen S; Zhang W; Chen Y; Zhu R; Deng A
    Neoplasma; 2015; 62(5):821-6. PubMed ID: 26278156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer.
    Peng W; Lin C; Jing S; Su G; Jin X; Di G; Shao Z
    Front Oncol; 2021; 11():746763. PubMed ID: 34604089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.
    Feng Y; Sun B; Li X; Zhang L; Niu Y; Xiao C; Ning L; Fang Z; Wang Y; Zhang L; Cheng J; Zhang W; Hao X
    Breast Cancer Res Treat; 2007 Jul; 103(3):319-29. PubMed ID: 17123152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of a 92-probe signature in breast cancer.
    Akter S; Choi TG; Nguyen MN; Matondo A; Kim JH; Jo YH; Jo A; Shahid M; Jun DY; Yoo JY; Nguyen NN; Seo SW; Ali L; Lee JS; Yoon KS; Choe W; Kang I; Ha J; Kim J; Kim SS
    Oncotarget; 2015 Jun; 6(17):15662-80. PubMed ID: 25883221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences.
    Mittempergher L; Saghatchian M; Wolf DM; Michiels S; Canisius S; Dessen P; Delaloge S; Lazar V; Benz SC; Tursz T; Bernards R; van't Veer LJ
    Mol Oncol; 2013 Oct; 7(5):987-99. PubMed ID: 23910573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
    Han J; Choi YL; Kim H; Choi JY; Lee SK; Lee JE; Choi JS; Park S; Choi JS; Kim YD; Nam SJ; Nam BH; Kwon MJ; Shin YK
    Breast Cancer Res Treat; 2017 Jul; 164(1):41-56. PubMed ID: 28409241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of 70-gene prognosis signature in node-negative breast cancer.
    Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
    Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy-related prognostic signature for breast cancer.
    Gu Y; Li P; Peng F; Zhang M; Zhang Y; Liang H; Zhao W; Qi L; Wang H; Wang C; Guo Z
    Mol Carcinog; 2016 Mar; 55(3):292-9. PubMed ID: 25620657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial.
    Aalders KC; Kuijer A; Straver ME; Slaets L; Litiere S; Viale G; Van't Veer LJ; Glas AM; Delorenzi M; van Dalen T; Tryfonidis K; Piccart MJ; Cardoso F; Rutgers EJ;
    Eur J Cancer; 2017 Jul; 79():98-105. PubMed ID: 28477490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.
    Foekens JA; Atkins D; Zhang Y; Sweep FC; Harbeck N; Paradiso A; Cufer T; Sieuwerts AM; Talantov D; Span PN; Tjan-Heijnen VC; Zito AF; Specht K; Hoefler H; Golouh R; Schittulli F; Schmitt M; Beex LV; Klijn JG; Wang Y
    J Clin Oncol; 2006 Apr; 24(11):1665-71. PubMed ID: 16505412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 16 Yin Yang gene expression ratio signature for ER+/node- breast cancer.
    Xu W; Jia G; Cai N; Huang S; Davie JR; Pitz M; Banerji S; Murphy L
    Int J Cancer; 2017 Mar; 140(6):1413-1424. PubMed ID: 27925180
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Li Y; Yang X; Sun J; Zhao Y; Zhou Q; Hua B
    Pharmgenomics Pers Med; 2021; 14():1701-1713. PubMed ID: 35002288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refinement of breast cancer risk prediction with concordant leading edge subsets from prognostic gene signatures.
    Huang CC; Tu SH; Lien HH; Huang CS; Huang CJ; Lai LC; Tsai MH; Chuang EY
    Breast Cancer Res Treat; 2014 Sep; 147(2):353-70. PubMed ID: 25158930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel gene expression signature for bone metastasis in breast carcinomas.
    Savci-Heijink CD; Halfwerk H; Koster J; van de Vijver MJ
    Breast Cancer Res Treat; 2016 Apr; 156(2):249-59. PubMed ID: 26965286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series.
    Desmedt C; Piette F; Loi S; Wang Y; Lallemand F; Haibe-Kains B; Viale G; Delorenzi M; Zhang Y; d'Assignies MS; Bergh J; Lidereau R; Ellis P; Harris AL; Klijn JG; Foekens JA; Cardoso F; Piccart MJ; Buyse M; Sotiriou C;
    Clin Cancer Res; 2007 Jun; 13(11):3207-14. PubMed ID: 17545524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
    Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
    Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast.
    Do SI; Yoon G; Kim HS; Kim K; Lee H; Do IG; Kim DH; Chae SW; Sohn JH
    Anticancer Res; 2016 Sep; 36(9):4873-82. PubMed ID: 27630343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of bone marrow accumulation of Tc-99m tetrofosmin for subsequent development of distant metastases in breast cancer.
    Wakasugi S; Tsukuma H; Inaji H; Hashizume T; Noguchi A; Ohnishi T
    Ann Nucl Med; 2007 Oct; 21(8):429-37. PubMed ID: 17952551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.